EUCTR2015-005155-27-HR
Active, not recruiting
Phase 1
Comparison of the efficacy and safety of the fixed-dose combination of xylometazoline and dexpanthenol in SeptaNazal® and xylometazoline in nasal congestion in patients after surgery in the nose and paranasal cavity and in patients with acute rhinitis – SeptaNazal DOUBLE clinical study.
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- KRKA-FARMA d.o.o.
- Enrollment
- 223
- Status
- Active, not recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with acute rhinitis (Group 1\):
- •Aged 18\-60 years
- •Diagnosed with acute rhinitis
- •Can carry out intranasal administration of the investigational medicinal
- •Signed Informed consent form
- •Patients after nasal surgery or nasal cavities surgery (Group 2\):
- •Aged 18\-60 years
- •Recent nasal surgery or nasal cavities surgery (patients with chronic
- •rinosinusitis with nasal polyps (CRSwNP) and patients with chronic
- •rinosinusitis without nasal polyps (CRSsNP)
Exclusion Criteria
- •Hypersensitivity to the active substances or to any of the excipients
- •Dry nasal inflammation (rhinitis sicca)
- •History of transsfenoidal hypophysectomy or other surgical procedures in which the dura mater was exposed
- •Patients who are treated with drugs for local or systemic treatment of influenza, and sympathomimetic agents, which contain a medicament for the treatment for cough and/or cold
- •Pregnancy or breast\-feeding
- •Patients with asthma who require treatment with corticosteroids
- •Rhinitis medicamentosa
- •Chronic rhinitis
- •Patients treated with monoamine oxidase inhibitors (MAOIs) or other drugs that may raise blood pressure
- •Patients with increased intraocular pressure, in particular with angle\-closure glaucoma
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Comparison of the efficacy and safety of the fixed-dose combination of xylometazoline and dexpanthenol in SeptaNazal® and xylometazoline in nasal congestion in patients after surgery in the nose and paranasal cavity and in patients with acute rhinitis – SeptaNazal DOUBLE clinical study.asal congestion in patients after nasal surgery or nasal cavities surgery and in patients with acute rhinitisMedDRA version: 19.0Level: HLTClassification code 10028736Term: Nasal congestion and inflammationsSystem Organ Class: 100000004855Therapeutic area: Diseases [C] - Ear, nose and throat diseases [C09]EUCTR2015-005155-27-SIKrka, d.d., Novo mesto194
Not yet recruiting
Phase 4
To evaluate efficacy and safety of three drug combinations in patients with community acquired pneumonia and acute exacerbation of chronic bronchitisHealth Condition 1: null- community acquired pneumonia and acute exacerbation of chronic bronchitisCTRI/2012/01/002347Dr Sharif Tadvi80
Not yet recruiting
Not Applicable
A comparative study of effectiveness of Alpha2 agonist (Dexmedetomidine) versus opioid (fentanyl) for awake intubation using flexible bronchoscopeHealth Condition 1: O- Medical and SurgicalCTRI/2022/03/041196Vinayaka missions kirupanda variyar medical college and hospital
Not yet recruiting
Phase 2
A clinical trial to study the effects of two drugs, metformin lotion and zinc oxide cream in patients with melasma, a type of facial pigmentatioHealth Condition 1: L811- ChloasmaCTRI/2023/09/057901ITHYAMS
Completed
Phase 3
A clinical trial to study the effects of artesunate - lumefantrine combination and artemether - lumefatrine combination in the treatment of uncomplicated Plasmodium falciparum malaria.Health Condition 1: null- Uncomplicated Plasmodium falciparum malariaCTRI/2009/091/000434Ipca Laboratories Limited176